quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:42:57·59d
ANALYSTRating
Gossamer Bio Inc. logo

Gossamer Bio downgraded by Barclays with a new price target

GOSS· Gossamer Bio Inc.
Health Care
Original source

Companies

  • GOSS
    Gossamer Bio Inc.
    Health Care

Recent analyst ratings

  • Mar 23UpdateCantor Fitzgerald-
  • Feb 24UpdateWedbush$1.00
  • Feb 24UpdateBarclays$0.30
  • Feb 24UpdateLeerink Partners$1.00
  • Jan 28UpdateBarclays$9.00
  • Sep 10UpdateUBS$9.00

Related

  • SEC14d
    Gossamer Bio Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by Gossamer Bio Inc.
  • SEC30d
    Amendment: SEC Form SCHEDULE 13G/A filed by Gossamer Bio Inc.
  • ANALYST32d
    Gossamer Bio downgraded by Cantor Fitzgerald
  • INSIDER34d
    SEC Form 4 filed by Aranda Richard
  • INSIDER34d
    SEC Form 4 filed by Peterson Caryn
  • INSIDER34d
    SEC Form 4 filed by Smith Robert Paul Jr
  • INSIDER34d
    SEC Form 4 filed by Hasnain Faheem
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022